Method for determining drug resistance mutations in any of the non-structural protein regions NS3 to NS5B of Hepatitis C Virus (HCV) for genotypes 1 to 6

Details for Australian Patent Application No. 2009301125 (hide)

Owner Virco BVBA

Inventors Stuyver, Lieven Jozef; Koletzki, Diana; Berke, Jan Martin; Vandenbroucke, Ina Isabel; Vijgen, Leen Roger

Agent Shelston IP

Pub. Number AU-A-2009301125

PCT Pub. Number WO2010/040756

Priority 08165949.2 06.10.08 EP

Filing date 6 October 2009

Wipo publication date 15 April 2010

International Classifications

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

21 April 2011 PCT application entered the National Phase

  PCT publication WO2010/040756 Priority application(s): WO2010/040756

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009301131-New amide compounds as boosters of antivirals

2009301116-Deformable composite seal for bearing surfaces with a great lack of flatness